共 6 条
[1]
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
[J].
LANCET DIABETES & ENDOCRINOLOGY,
2017, 5 (05)
:355-366
[3]
Davies MJ, 2018, DIABETOLOGIA, V61, P2461, DOI [10.1007/s00125-018-4729-5, 10.2337/dci18-0033]
[4]
Case non-case studies: Principle, methods, bias and interpretation
[J].
THERAPIE,
2019, 74 (02)
:225-232